yeasts are approximately 30% identical over a shared domain consisting of eight leucine-rich repeats followed by a highly acidic stretch ( Figure 1A ). Whether mammalian RanGAP1, which contains an additional C-terminal extension ( Figure 1A , tail), was a true functional homolog of Rna1p remained to be established.
To analyze a possible role of mammalian RanGAP1 in nuclear protein import, we prepared two affinity-purified antibodies: one directed against full-length RanGAP1, and one directed against the mammalian-specific tail domain. We first investigated their effect on RanGAP1-induced GTP hydrolysis by Ran ( Figure 1B , left). Addition of 100 g/ml ␣GAP-tail antibodies had no measurable effect on RanGAP-stimulated GTP hydrolysis. In contrast, addition of only 20 g/ml ␣RanGAP1 antibodies completely abolished RanGAP-induced hydrolysis (Figure 1B, GAP ϩ ␣RanGAP) . We then measured the effect of these antibodies on nuclear import. ␣RanGAP1 antibodies strongly inhibited in vitro nuclear import in HeLa cells (Figure 1B, right) , with maximal inhibition (>90%) at 0.4 mg/ml antibody. This inhibition could be reversed by the addition of excess recombinant RanGAP1 prior to antibody addition (see Figure 7) . While the maximal level of inhibition varied somewhat from experiment to experiment, we routinely obtained >70% inhibition. In contrast, ␣GAP-tail antibodies had a much weaker inhibitory effect on import (Figure 1B, right) . The differential effects of these two antibodies on RanGAP1-stimulated gesting that the decrease in transport was at least partly GAP1 (Bischoff et al., 1995a) , its mouse homolog Fug1 (DeGregori mediated by inhibition of RanGAP activity. Taken toet al., 1994) , S. cerevisiae Rna1p (Traglia et al., 1989), and S. pombe gether, these data demonstrate that mammalian Ranrna1p (Melchior et al., 1993b) . All proteins contain eight leucine-rich GAP1 is required for nuclear protein import.
repeats and a highly acidic stretch, while the C-terminal tail domain of 185 amino acids is specific to mammalian RanGAP1. (B) Antibodies to RanGAP1 inhibit RanGAP1-induced GTP hydroly-
Antibodies to RanGAP1 Recognize Two Proteins
sis by Ran as well as in vitro nuclear import. Left: RanGAP1 (1 g/ with Apparent Molecular Masses ml)-stimulated GTP hydrolysis by Ran was measured in the absence of 70 kDa and 90 kDa (GAP only) or presence of 20 g/ml antibodies raised against fullBiochemical fractionation of HeLa cells has raised the length RanGAP1 (GAP plus ␣RanGAP) or 100 g/ml antibodies possibility that mammalian cells may contain several raised against the C-terminal tail domain (GAP plus ␣GAP-tail) . No related RanGAP proteins (Bischoff et al., 1994) . We in-GAP: endogeneous hydrolysis rate of Ran-GTP in the absence of RanGAP1. Right: in vitro nuclear protein import was measured in vestigated this question by performing Western blot the presence of increasing concentrations of ␣RanGAP1 or ␣GAP-analysis of several cell extracts (see Figure 1C ). Interesttail antibodies. ingly, both ␣RanGAP1 and ␣GAP-tail antibodies consis-(C) Antibodies to RanGAP1 reveal both the 70-kDa and the 90-kDa tently recognized two proteins: one with an apparent RanGAP1-related proteins in several cell extracts. Samples resolved molecular mass of 70 kDa that comigrated with recombion an 8% SDS gel were immunoblotted with ␣RanGAP1 or ␣GAP-nant mouse RanGAP1, and one that migrated at an aptail antibodies. RanGAP, 3 ng of recombinant RanGAP1. Cell extracts from HeLa, NRK, and NIH 3T3 tissue culture cells were preparent molecular mass of 90 kDa. The staining pattern pared by lysis of cells in boiling SDS gel-loading buffer, whereas obtained with both antibodies was virtually identical rat liver extract was prepared by homogenization of rat liver in a ( Figure 1C) , suggesting that the 70-kDa and 90-kDa physiological buffer prior to addition of 2ϫ SDS gel loading buffer.
bands are both related to RanGAP1. The ratio of the two bands was dependent on the method of sample cannot be overcome by addition of soluble RanGAP1.
preparation. When tissue culture cells were scraped diThese findings suggest that GTP hydrolysis by Ran ocrectly into boiling SDS-polyacrylamide gel electrophorecurs at RanBP2 during nuclear protein import. sis (PAGE) loading buffer, both bands were present in approximately equal abundance ( Figure 1C ). In contrast, Results when rat liver ( Figure 1C ) or HeLa cells (data not shown) were lysed under nondenaturing conditions prior to adMammalian RanGAP1 Is Involved in Nuclear dition of SDS, the 90-kDa band predominated. Protein Import Rna1p, the only identified S. cerevisiae RanGAP, is re-
The 90-kDa RanGAP1-Related Protein quired for nuclear protein import (Corbett et al., 1995) .
Is Highly Enriched in NEs The 64-kDa mammalian RanGAP1 (Bischoff et al., 1995a) To characterize further the 90-kDa RanGAP-like protein, we analyzed its subcellular distribution by fractionation and the 44-kDa Rna1 proteins from fission and baker's (A) The 90-kDa RanGAP1-related protein is highly enriched in rat liver NEs. Equivalent amounts of subcellular fractions of rat liver were resolved on an 8% SDS gel and immunoblotted with ␣RanGAP1 antibodies. Total was taken after homogenization of rat liver. P1 and SN1, pellet and supernatant of the first low speed centrifugation; Nuclei, purified nuclei; DNase Sup, the supernatant of the first DNase/RNase digest of the nuclei; NEs, the final NE fraction. NE proteins were enriched ‫-052ف‬fold. Note that under these conditions, the 90-kDa protein is the only ␣RanGAP1-reactive species detected. (B) Appearance of the 70-kDa ␣RanGAP1-reactive species upon salt extraction of the NE fraction. NEs containing the 90-kDa protein were incubated with 500 mM NaCl and centrifuged, and the supernatant (Sup) and pellet (Pellet) were analyzed by Western blotting. (C) Immunoprecipitation with ␣RanGAP1 antibodies from solubilized rat liver NEs. NEs were solubilized and incubated overnight with ␣RanGAP1 antibodies preadsorbed to Protein A beads. Antibody-antigen complexes and the remaining supernatant were separated on 8% gels and either stained with Coomassie blue or immunoblotted with ␣GAP-tail antibodies. The lower band ‫23ف(‬ kDa) results from a nonspecific interaction with the Protein A beads (see Figure 6 ). Asterisk, IgG heavy chain.
of rat liver homogenates ( Figure 2A ). Whereas a fraction This suggested that the 90-kDa protein might represent an alternatively spliced form of the previously identified of the protein was present in the low speed supernatant (and remained in a subsequent high speed supernatant; 70-kDa RanGAP1, or an SDS-PAGE-resistant protein complex of the 70-kDa RanGAP1 with another protein. data not shown), the majority of the protein was present in the nuclear fraction. DNase/RNase digestion of nuclei, which releases most nuclear contents, did not solubilize Identification of a Novel Ubiquitin-Related Protein a significant amount of the 90-kDa protein, indicating
The peptide sequences obtained from the 90-kDa-spethat a major fraction of the 90-kDa protein is associated cific HPLC peaks (Table 1 , P2-P4) were used to search with the NE. Extraction of NEs with high salt resulted in for related sequences in the DNA databases. While no the appearance of a 70-kDa band in addition to the homology to known protein sequences was found, 30 expected 90-kDa band ( Figure 2B ). About 50% of the overlapping expressed sequence tag (EST) cDNAs from 90-kDa band remained in the pellet after salt extraction, the Human cDNA Database were identified that encoded but the 70-kDa band was specifically enriched in the all three peptides. The three longest of these clones supernatant ( Figure 2B ; compare supernatant with pelwere sequenced and found to contain the same putative let). The appearance of the 70-kDa protein suggested open reading frame (ORF) of 101 amino acids that inthat this species might derive from the 90-kDa protein by cluded the three unique peptide sequences present in proteolysis or by loss of a hypothetical posttranslational the 90-kDa RanGAP protein. The cDNA sequence and modification.
the deduced protein sequence of the ORF are shown in Figure 3A . The small calculated size of the protein The 90-kDa RanGAP1-Related Protein (11.5 kDa) suggested that the protein could be postContains a Domain Absent from the translationally coupled to RanGAP1 to yield the 90-kDa Recombinant 70-kDa RanGAP1 species. However, since the cDNAs contained no upTo investigate the relationship between the 90-and stream stop codons, it was formally possible that this 70-kDa protein bands, we solubilized rat liver NEs in sequence represented an ORF downstream of the origiradioimmunoprecipitation assay (RIPA) buffer, immunonal published RanGAP1 mRNA sequence, and that a precipitated the two bands with ␣RanGAP1 antibodies hypothetical 5Ј section encoding a RanGAP1-related ( Figure 2C ), and analyzed tryptic digests of the two species on a C18 high pressure liquid chromatography (HPLC) column. While the HPLC profiles of tryptic di- demonstrated that none of these sequences was pres-P2-P4 are specific for the 90-kDA protein.
ent in, or related to, the published RanGAP1 sequence. (A) cDNA sequence and deduced amino acid sequence of SUMO-1. The ORF codes for a protein of 101 amino acids with a predicted molecular mass of 11.5 kDa. The three unique peptides detected in the 90-kDa RanGAP protein are present in the ORF (underlined; see also Table 1 ).
(B) Northern blot analysis of RanGAP1 and SUMO-1 mRNAs. Hela total RNA (20 g) was separated on a formaldehyde gel, transferred onto nitrocellulose, and probed with 32 P-labeled DNA fragments of RanGAP1 or SUMO-1. (C) SUMO-1 is a member of a ubiquitin-related protein family. The BLAST search algorithm was used to identify proteins homologous to SUMO-1. The following proteins were aligned: the deduced protein sequence of a partially sequenced rat EST cDNA clone that is virtually identical to human SUMO-1 (Rat SUMO-1, EST108203); human and S. cerevisiae SMT3; ubiquitins from human, Dictyostelium discoideum, S. cerevisiae, and Arabidopsis thaliana; and Nedd-8 from mouse. Dark shading, residues in rat SUMO-1 and the SMT3 proteins that are identical to corresponding positions of human SUMO-1. Light shading, residues in ubiquitins and Nedd-8 that are identical to human ubiquitin. Box, residues identical among human and rat SUMO-1 and ubiquitins. Asterisks, residues identical in all proteins compared. Consensus sequence below is defined by residues that are either identical or highly homologous among members of the SUMO-1, SMT3, and ubiquitin families.
sequence was missing from all the EST clones. This sequenced EST cDNA encoding a nearly identical protein from rat) shows 18% identity to ubiquitin. Our datapossibility was addressed by Northern blot analysis of total HeLa RNA with a 1.1 kb fragment of RanGAP1 base search revealed three additional proteins related both to the 11.5-kDa protein and to ubiquitin: the ubiquicDNA and a 430 bp fragment of the EST clones, including the entire ORF ( Figure 3B ). As reported previously for tin-like mouse protein Nedd8, of unknown function (Kumar et al., 1993) , with 58% identity to ubiquitin and 20% mouse RanGAP1 (DeGregori et al., 1994) , only a single band was detected for HeLa RanGAP1. Moreover, the identity to the 11.5-kDa protein; human SMT3 (Mannen et al., 1996) , with 16% identity to ubiquitin and 47% only band obtained by hybridization with the EST fragment was similar to the size of the longest EST clone identity to the 11.5-kDa protein; and S. cerevisiae SMT3 (Meluh and Koshland, 1995 ; GenBank accession num-(1.42 kb). These data indicate that the RanGAP1 sequence and the 90-kDa protein-specific sequence are ber U27233), with 16% identity to ubiquitin and 52% identity to the 11.5-kDa protein. While the level of identity encoded by two separate mRNAs, implying that the 90-kDa band observed after immunoprecipitation and SDSamong the ubiquitin/11.5-kDa, ubiquitin/SMT3, and Nedd8/11.5-kDa pairs is very low, sequence alignment PAGE contains a stable complex between the 70-kDa RanGAP1 and the putative 11.5-kDa protein.
clearly revealed that these proteins are related. Of the 76 amino acid residues in ubiquitin, 32 (42%) are either Using the basic local alignment search tool (BLAST) algorithm, we found that this protein (and a partially identical or highly conserved in all proteins ( Figure 3C , consensus). Since the 11.5-kDa protein is functionally related to ubiquitin (see below), we have named it small ubiquitin-related modifier (SUMO-1).
SUMO-1 Converts the 70-kDa RanGAP1 to a 90-kDa Protein
The homology of the 11.5-kDa SUMO-1 to ubiquitin suggested that it might be involved in converting the 70-kDa RanGAP1 to the 90-kDa form through a posttranslational covalent modification. To address this question, we used affinity-purified ␣SUMO-1 antibodies in Western blot analysis of nuclear fractions ( Figure 4A ) and in immunoprecipitates of RanGAP1 from solubilized NEs ( Figure 4B ). SUMO-1 antibodies strongly react with 90-kDa RanGAP1 but not with 70-kDa RanGAP1, supporting the idea that 90-kDa RanGAP1 is modified with SUMO-1. Interestingly, while 90-kDa RanGAP1 is the major immunoreactive band in nuclei, ␣SUMO-1 antibodies detected three additional nuclear proteins with molecular masses of ‫021ف‬ kDa and 140-150 kDa that are specifically enriched in the nuclear content fraction ( Figure 4A , DNase supernatant). Ubiquitination is accomplished by an ATP-dependent process (reviewed by Ciechanover, 1994; Hochstrasser, 1995) and can be achieved in vitro because cells contain an excess of the ubiquitin moiety. To determine whether SUMO-1 modification of RanGAP1 showed similar characteristics, we incubated recombinant RanGAP1 with a Figure 4C shows that the 70-(A) Antibodies raised against SUMO-1 react with a 90-kDa band in kDa recombinant RanGAP1 was shifted in a time-depenrat liver nuclei. Antibodies raised against recombinant SUMO-1 were dent fashion to a 90-kDa band in the cell extract conused to probe rat liver nuclear fractions. Nuclei, DNase supernatant, taining ATP. This reaction was extremely rapid, as a and NEs were prepared as before (see Figure 2A ) and subjected to immunoblotting. ␣SUMO-1 antibodies react with a 90-kDa band and significant fraction of the protein was already converted with three additional bands (open arrows) that are released with the RL1, ␣RanGAP1 also stained the cytoplasm. The same staining pattern was obtained with ␣GAP-tail antibodies RanGAP1 Is Localized Predominantly at the NPC To localize the 70/90-kDa RanGAP1, we analyzed nor-(data not shown). Cytoplasmic staining was lost when cells were permeabilized with digitonin prior to fixation mal rat kidney (NRK) cells by double immunofluorescence staining with ␣RanGAP1 antibodies and with the (data not shown), indicating that the cytoplasmic pool of RanGAP1 is soluble. Confocal images of the cells NPC-specific RL1 monoclonal antibodies, which recognize a family of O-linked glycoproteins of the NPC (Snow ( Figure 5B ) showed nuclear rim staining in an equatorial view and punctate labeling in a nuclear surface view. et al., 1987) . Immunofluorescence microscopy ( Figure  5A) showed that like RL1, ␣RanGAP1 antibodies decoThis is virtually identical to the pattern of RL1 staining and suggests localization of RanGAP1 to NPCs. The rate predominantly the NE. However, in contrast with Immunogold labeling of isolated rat liver NEs with ␣RanGAP1 antibodies ( Figure 5C ) resulted in the exclusive decoration of the cytoplasmic surface of the NE, specifically at NPCs. Most of the labeling was found in peripheral regions of the NPC, at a distance of 52 (Ϯ 14) nm (n = 101) from a plane bisecting the NPC into nucleoplasmic and cytoplasmic halves. This is very similar to the localization of the Ran-GTP-binding site at the NPC (Melchior et al., 1995a) and to the localization of RanBP2/Nup358 (Wu et al., 1995; Yokoyama et al., 1995) , which is the putative site of initial substrate binding during nuclear import.
The 90-kDa SUMO-1-RanGAP1 Conjugate but Not 70-kDa RanGAP1 Stably Interacts with RanBP2
The similar localizations of RanGAP1 and RanBP2 at the cytoplasmic periphery of the NPC, and the presence of a >300-kDa protein in the immunoprecipitate of Ran-GAP1 from NEs (see Figure 2C , Coomassie P), suggested that RanGAP1 might be associated in vivo with the 358-kDa RanBP2. To address this possibility, we investigated whether these two polypeptides could be coimmunoprecipitated from samples of NEs solubilized in RIPA buffer by ␣RanGAP1 and ␣RanBP2 antibodies. Figure 6A shows that both ␣RanGAP1 and ␣RanBP2 antibodies precipitate the 90-kDa RanGAP1-SUMO-1 conjugate and RanBP2. This demonstrates that RanBP2 is indeed present in a stable complex with RanGAP1. Interestingly, this stable association seems to be specific for the 90-kDa modified RanGAP1 species, since ␣RanBP2 antibodies failed to precipitate the 70-kDa unconjugated form of RanGAP1, even though a significant amount of 70-kDa protein was generated upon solubilization of the envelopes (Figure 6A , right; compare S and P). This suggests that the interaction between RanGAP1 and RanBP2 involves the SUMO-1 modification. This interaction is likely to be direct, as no additional specific bands could be detected in the ␣RanGAP1 immunoprecipitate ( Figure 6A , Coomassie). Additional proteins present in the ␣RanBP2 immunoprecipitate are most der conditions in which only 50% of the protein was Shown are thin section electron micrographs of isolated rat liver NEs displaying NPCs either in cross sections (A-E) or in tangential shifted to the 90-kDa species (as shown in Figure 4C proteins were partially purified by ion exchange chromaScale bar, 100 nm. tography followed by molecular sieving. As shown by silver staining ( Figure 6B , 70/90 mix), only a few addiabsence of cytoplasmic staining in optical sections obtional proteins are present in the final 70/90 mixture. tained with confocal microscopy suggests that the cytoThese proteins are unlikely to interact with RanGAP1, plasmic concentration of RanGAP1 is significantly lower as they elute in different peak fractions from the 90-than the concentration at the NE. This interpretation is kDa RanGAP1. Moreover, the 70-kDa and the 90-kDa consistent with the biochemical fractionation of rat liver, RanGAP1 elute very close together, and the 70-kDa prowhich revealed a strong enrichment of RanGAP1 in NEs tein in the 70/90 mix elutes in exactly the same position as untreated recombinant RanGAP1 (data not shown). (at least 100-fold over SN1; see Figure 2A ). of 0.5 mg/ml ␣RanGAP1 antibodies. Unbound antibodies were re-(A) Immunoprecipitation from solubilized NEs using both ␣RanGAP1 moved, and cytosol, substrate, and ATP-regenerating system were and ␣RanBP2 antibodies was carried out as in Figure 2C . A control added before initiating nuclear protein import at 30ЊC. Lanes 8 and reaction with Protein A-Sepharose beads alone (no antibody) was 9, addition of 2 g/ml recombinant RanGAP1 to the transport mix. carried out in parallel. Immunoprecipitates were resolved on a 5%-Lanes 10 and 11, addition of 10 g/ml recombinant RanGAP1. Lane 15% gradient SDS gel and analyzed by Coomassie blue staining 12, antibodies preincubated (asterisk) with recombinant RanGAP (left) and blot overlay analysis with [ 32 P]GTP-Ran to identify RanBP2 (50 g/ml final concentration on the permeabilized cells) for 15 min (middle). Distribution of the 70-kDa and 90-kDa RanGAP1 was deterprior to addition to the permeabilized cells demonstrate specificity mined by immunoblotting of supernatants (S) and pellets (P) with of the inhibition. Mean values are shown; error bars indicate actual ␣RanGAP1 antibodies (right). Asterisk, IgG heavy chain.
values of duplicate experiments. (B) RanBP2 and an in vitro generated mixture of 70-kDa and 90-kDa RanGAP1 were used in the binding assay. RanBP2 was purified from rat liver NEs, resolved on a 5%-15% SDS gel, and identified 100-fold excess of SUMO-1 (data not shown). The bindby silver staining. The 70/90 mix of RanGAP1 was generated from ing of the 70-kDa unmodified RanGAP1 to RanBP2-recombinant RanGAP1 (see Experimental Procedures), and the components of the partially purified mix were identified by silver coated wells, observed primarily at the highest concen- The existence of a cytosolic pool of RanGAP1 (approximately 30%-40% of the total RanGAP1) raised the question of whether this pool has a specific role in nuclear protein import. It has been proposed that Ran-GDP is We purified the 358-kDa protein RanBP2 from rat liver to homogeneity by using affinity chromatography folrequired at the cytoplasmic side of the NPC (Nehrbass and Blobel, 1996) . According to this model, RanGAP1 lowed by ion-exchange chromatography ( Figure 6B , RanBP2). The purified protein was bound to microtiter might simply be required to recycle Ran-GDP. In this case, exogenously added Ran-GDP would be expected wells and incubated with increasing concentrations of the 70/90-kDa RanGAP1 mixture (0.2 g/ml to 4.0 g/ to relieve ␣RanGAP-mediated inhibition. As shown in Figure 7A , the addition of 50 g/ml Ran-GDP had no ml, equivalent to 3-60 nM; Figure 6C ). After washing, the bound fraction was solubilized with SDS gel loading effect on antibody-inhibited nuclear protein import. However, since Ran is readily able to diffuse in and buffer and analyzed by immunoblotting ( Figure 6C , bound). As a specificity control, the 70/90-kDa mix was out of the nucleus , we could not exclude the possibility that rapid exchange of GTP for also incubated with BSA-coated microtiter wells. Even though the 70/90 mix contained more than 50% unmodi-GDP by nuclear RCC1 was reducing the effective concentration of exogenous Ran-GDP. To address this fied RanGAP1 ( Figure 6C, load) , nearly all of the Ran-GAP1 that bound to RanBP2 was of the 90-kDa modified question, we performed a second experiment, shown in Figure 7B , in which only NPC-bound RanGAP1 was form. This binding was not competed by addition of a inhibited by preincubation of permeabilized cells with 1996), and the S. cerevisiae SMT3. No function has yet been established for these proteins, and we speculate the antibodies. Antibody-treated cells were washed to remove unbound antibodies, combined with untreated that they may also function as covalent modifiers. cytosol or cytosol plus recombinant RanGAP1, and used for transport assays. This pretreatment of cells led to a Stable Modification of RanGAP1 by SUMO-1 significant ‫)%05ف(‬ inhibition of nuclear import, which
In contrast with most ubiquitinated proteins, RanGAP1 could not be relieved by addition of either a 10-or a 50-modified by SUMO-1 seems to be metabolically stable. fold excess of recombinant RanGAP1 over the inhibited No higher molecular mass RanGAP1 conjugates, indica-NPC-associated RanGAP1. This experiment clearly tive of polyubiquitination and a ubiquitin-mediated degdemonstrates that inhibition of import by antibodies to radation pathway, can be detected in intact cells or upon RanGAP1 is not simply caused by depletion of Ranin vitro modification. Moreover, the predominant site GDP or accumulation of Ran-GTP, because recombirequired for assembly of polyubiquitin chains on target nant RanGAP1 is very effective in converting Ran-GTP proteins, lysine residue 48 in ubiquitin, is absent in to Ran-GDP (see Figure 1B) . The reduced level of inhibi-SUMO-1. These findings suggest that modification of tion in this case, compared with experiments where high RanGAP1 by SUMO-1 does not target RanGAP1 for degconcentrations of antibodies were present throughout radation. the import reaction (see Figures 1B and 7A) , is likely to Modified and unmodified forms of RanGAP1 are likely be due to dissociation of antibodies during the transport to be present in a dynamic equilibrium in vivo, as interreaction or to limited access of antibodies to RanGAP conversion is possible in vitro (see Figures 2B and 4C ). in the preincubation step. Transport inhibition by ␣Ran-Complete conversion to the 70-kDa form occurs upon GAP1 antibodies was also observed in reconstituted fractionation of cytosol or high salt extracts of NEs over assays lacking cytosolic RanGAP1, in which cytosol was molecular sieving columns, presumably owing to separeplaced with recombinant cytosolic factors (Ran-GDP, ration of free SUMO-1 protein (unpublished data). Our NTF2, p97, and Srp1␣). These results indicate that data suggest that both conjugating and cleaving enRanBP2-associated RanGAP1 is required for nuclear zymes are present in cell extracts. However, in total cell import, and that cytosolic RanGAP1 cannot substitute extracts, the modification of RanGAP1 is much more for this requirement.
rapid than its demodification, suggesting that in vivo the RanGAP1-SUMO-1 conjugate is a long-lived species.
Discussion

SUMO-1 Is Involved in Targeting RanGAP1 to the NPC Protein RanBP2 SUMO-1, a Novel Ubiquitin-Related Protein
We found that RanGAP1 is highly concentrated at the We have identified a novel polypeptide of 101 amino NPC and forms a stable complex with RanBP2. Three acids (SUMO-1) that is covalently linked to RanGAP1 in lines of evidence argue that this interaction requires the an ATP-dependent reaction. SUMO-1 shows a low, but modification of RanGAP1 with SUMO-1. First, when NEs significant, homology to ubiquitin, a highly conserved are solubilized with RIPA buffer and a significant fraction 76-residue protein found in eukaryotes that is conjuof modified RanGAP1 becomes demodified, ␣RanBP2 gated via its C-terminal carboxyl group to lysine ⑀-amino antibodies coprecipitate only the modified RanGAP1. groups of acceptor proteins (reviewed by Ciechanover, Second, when NEs are extracted with high salt (condi-1994; Hochstrasser, 1995) . The ATP-dependant ubiquititions that do not solubilize a significant amount of nation reaction, which involves a cascade of enzymatic RanBP2), modified RanGAP1 distributes evenly bereactions, is best known for its ability to initiate regulated tween supernatant and pellet, while 70-kDa RanGAP1 protein degradation by a complex called the 26S proteais nearly completely soluble. Third, in binding assays some. Commitment of a target protein to the degradawith purified rat liver RanBP2 and a mixture of modified tion pathway involves assembly of a polyubiquitin chain and unmodified RanGAP1, only modified RanGAP1 on the target, often via isopeptide bonds between lysine binds to RanBP2. Taken together, these data indicate 48 of one ubiquitin and the C-terminus of the neighthat the ubiquitin-related modification of RanGAP1 boring ubiquitin (Ciechanover, 1994) . However, examserves to target RanGAP1 to RanBP2. Saitoh et al. (1996) ples of metabolically stable ubiquitin conjugates conrecently reported that an 88-kDa protein that coimmunotaining a single ubiquitin moiety, such as Ub-histone precipitates with RanBP2 from a Xenopus laevis egg H2A, have been documented, and it is becoming inextract contains peptide sequences found in RanGAP1 creasingly evident that the role of the ubiquitin modificaas well as some additional unique sequences. It seems tion is not limited to a degradation signal (reviewed by likely that this 88-kDa protein is in fact modified Hochstrasser, 1996) .
RanGAP1. This theme is extended by the present study, in which we demonstrate that SUMO-1 is a ubiquitin-related protein modifier that appears to be involved in protein tarRanBP2-Associated RanGAP1 Is Required in Nuclear Protein Import geting and not degradation. Immunoblot analysis indicates that at least three additional intranuclear proteins Although the requirement for GTP hydrolysis by Ran during nuclear import is well established, the site of GTP are modified with SUMO-1 or with a protein very closely related to it. Our database search revealed three prohydrolysis has remained a matter of dispute. Models involving either single (Melchior et al., 1995a) is an essential part of nuclear protein import. Together (TB; Melchior et al., 1995b) . Expression and purification of GSTwith our previous finding that Ran accumulates at GAP-tail, GST-RanBP2, and GST-SUMO-1 fusion proteins followed RanBP2 when it cannot hydrolyze its GTP (Melchior et standard procedures. Pure SUMO-1 was obtained by thrombin dial., 1995), these data support a model in which nuclear gestion of GST-SUMO-1 bound to gluthathione beads and gel filtraimport involves a single round of Ran-GTP hydrolysis tion of the resulting supernatant. Recombinant Ran/TC4 was expressed as described by Melchior et al. (1995b) .
at RanBP2. While we cannot rule out that GTP hydrolysis by Ran may also occur at other sites, there is currently Antibodies no direct evidence to support this, as far as we know.
Rabbits were injected with 500 g of protein (RanGAP1, GAP-tail,
RanBP2 is localized at fibrils emanating from the cyto- (Panté and Aebi, 1996b) .
by adsorption to affinity columns containing recombinant protein RanBP2 contains Ran-GTP-binding domains as well as and subsequent elution with 0.2 M acetic acid (pH 2.7), 0.5 M NaCl. RL1 monoclonal antibodies are described by Snow et al. (1987) .
FG repeat domains, which can interact with a complex
Peroxidase-conjugated goat ␣rabbit immunoglobulin G (IgG) was containing NLS receptor, p97, and substrate in vitro from Pierce, rhodamine-conjugated donkey ␣rabbit IgG and FITC-(e.g., Hu et al., 1996) . Several possible functions for Ranconjugated goat ␣mouse IgG from Jackson ImmunoResearch, and GTP and the hydrolysis step can be envisioned. For 5-nm colloidal gold conjugated to goat ␣rabbit IgG from Zymed.
example, the NLS receptor-substrate-p97 complex and Ran-GTP might initially interact with RanBP2 at the cyto-
Preparation of Rat Liver NEs and Immunoprecipitation
plasmic fibrils (Melchior et al., 1995a, Panté and Aebi, NEs were prepared as described by Snow et al. (1987) . For immunoprecipitation, NEs were solubilized at an OD 260 of 100 in RIPA buffer 1996b). After receptor-substrate-p97 and RanGTP have , 150 mM NaCl, 1% Nonidet P-40, 0.5% bound to RanBP2, RanGAP1 would stimulate GTP hydeoxycholate, 0.1% SDS, 1 mM DTT, 0.1 mM PMSF, 1 g/ml each drolysis by Ran to commit the transport complex to of leupeptin, pepstatin A, and aprotinin) for 2 hr on ice and centrimore distal steps of the import pathway. In another fuged at 100,000 ϫ g for 30 min. Antibodies (10 g) (␣RanGAP1 or scenario, Ran-GTP might form a complex with p97 in␣RanBP2) prebound to 5 l of protein A-Sephacryl beads (Pierce) side the nucleus during disassembly of a transport comwere added to each 100 OD of solubilized NEs and incubated overnight on ice. After three washes in RIPA buffer, antigen-antibody plex. The p97-Ran-GTP complex could then exit the complexes were solubilized in SDS-PAGE loading buffer.
nucleus and bind to RanBP2, where RanGAP1-induced GTP hydrolysis would release Ran-GDP from the com- the data presented here strongly favor models of nuclear g/ml ␣RanGAP1 or ␣GAP-tail, 5 g/ml ␣SUMO-1, and 1 g/ml protein import in which the localization of RanGAP1 at ␣RanBP2 antibodies in 5% milk powder in PBS, 0.2% Tween 20 for the cytoplasmic periphery of the NPC imparts vectori-1 hr at room temperature. Detection was by enhanced chemiluminescence (Amersham).
ality to the import pathway.
For indirect immunofluorescence using light or confocal microscopy, NRK cells were fixed on coverslips with 3.7% formaldehyde Experimental Procedures in PBS and processed as described by Melchior et al. (1995b) . Antibodies were used at 0.5 g/ml (␣RanGAP1) and at a 1:200 dilu-DNA Cloning and Northern Blot Hybridization tion (RL1 ascites fluid). For immunogold electron microscopy, rat RanGAP1 cDNA obtained by reverse transcription of NIH 3T3 mRNA liver NEs (200 OD 260 /ml) were incubated with 10 g/ml ␣RanGAP1 and subsequent polymerase chain reaction (PCR) was cloned into in PBS/Mg, 0.5% BSA for 2 hr at room temperature, and processed the pET-11d vector (Novagen). Amino acids 400-589 of the coding as described by Melchior et al. (1995a) . sequence were cloned into the pGEX-2T plasmid (Pharmacia) to create a GST-GAP-tail fusion protein, and amino acids 1592-1766 of RanBP2 were cloned into pGEX-2T to create a GST-RanBP2
Blot Overlay and GAP Assays Recombinant Ran was loaded with [␣-32 P]GTP and blot overlays fusion protein. A cDNA fragment encoding the ORF of SUMO-1 was obtained by PCR from the I. M. A. G. E. Consortium cDNA clone with [␣-32 P]Ran-GTP were carried out as described by Melchior et al. (1995a) . GAP assays were initiated by adding 2 l of [␣-
32 P]Rannumber 49768 and was cloned into pGEX-2T to create a GST-SUMO-1 fusion protein. I. M. A. G. E. Consortium cDNA clones GTP (40 g/ml final concentration) to 8 l of recombinant RanGAP1
(1 g/ml final concentration) in TB in the absence or presence of (numbers 49768, 51818, and 199507; Lennon et al., 1996) , containing the SUMO-1 ORF, were sequenced at the core facility of The Scripps 20 g/ml ␣RanGAP1 or 100 g/ml of ␣GAP-tail antibodies. At the
